Sanofi Consumer Healthcare India Limited SANOFICONR
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Daily technical summary
Calculated in the browser from validated historical candles. This is descriptive research, not a buy or sell recommendation.
Financial statements
IND AS · INR crore
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 547 | 431.3 | 345.4 |
| Accumulated Depreciation Total | -14.3 | -6 | -2.5 |
| Cash Equivalents | 371.3 | 322.9 | 0 |
| Other Liabilities Total | 17.5 | 11.1 | 7.9 |
| Accrued Expenses | 24.6 | 24.4 | 12.9 |
| Common Stock Total | 23 | 23 | 2 |
| Prepaid Expenses | 1.2 | 2 | 0 |
| Total Assets | 547 | 431.3 | 345.4 |
| Current Portof LT Debt/Capital Leases | 7.7 | 3.7 | 0 |
| Cash | 3.9 | 4 | 1.6 |
| Total Equity | 384 | 273 | 207.6 |
| Retained Earnings(Accumulated Deficit) | 361 | 250 | 182.6 |
| Total Common Shares Outstanding | 2.3 | 2.3 | 2.3 |
| Property/Plant/Equipment Total-Gross | 49.4 | 33.9 | 4.5 |
| Tangible Book Valueper Share Common Eq | 166.39 | 117.71 | 87.75 |
| Total Liabilities | 163 | 158.3 | 137.8 |
| Total Debt | 24.8 | 20.3 | 0 |
| Short Term Investments | 0 | Not available | Not available |
| Cashand Short Term Investments | 375.2 | 326.9 | 1.6 |
| Total Receivables Net | 56 | 21.9 | 237 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Accounts Receivable-Trade Net | 29.6 | 13.7 | 31.6 |
| Property/Plant/Equipment Total-Net | 35.1 | 27.9 | 2 |
| Total Current Liabilities | 128.4 | 130.6 | 129.9 |
| Total Inventory | 61.9 | 40.9 | 96.6 |
| Accounts Payable | 79.6 | 70.3 | 60 |
| Other Currentliabilities Total | 16.5 | 32.2 | 57 |
| Total Long Term Debt | 17.1 | 16.6 | 0 |
| Intangibles Net | 0.8 | 1.9 | 5.5 |
| Other Long Term Assets Total | 11 | 8.6 | 1.9 |
| Note Receivable-Long Term | 5.8 | 1.2 | 0.8 |
| Total Current Assets | 494.3 | 391.7 | 335.2 |
| Capital Lease Obligations | 17.1 | 16.6 | 0 |
| Other Equity Total | Not available | 0 | 23 |
Valuation and ratios
Margins
Operating Margin 12m35.03
Net Profit Margin 12m27.58
Yield
Dividend Yield %1.64
Valuation
Price to Sale Ratio1.21
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk36.13
Recommendations
RatingStrong Buy
Target High5,493.1
Target Low3,950.5
Target Mean1
Target Median0
Analyst count, source and as-of date are not provided; target values should be treated as unverified.Peer comparison
Only peers present in the company profile payload are displayed.
| Symbol | Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|---|
| — | Sun Pharmaceutical Industries | INR 1,935.55 | 4.64 L | 38.4 | — |
| — | Divi's Laboratories | INR 7,369 | 1.96 L | 73.32 | — |
| — | Torrent Pharmaceuticals | INR 4,968.1 | 1.68 L | 72.73 | — |
| — | Cipla | INR 1,405.1 | 1.14 L | 27.57 | — |
| — | Zydus Lifesciences | INR 1,118.6 | 1.11 L | 21.19 | — |
Ownership
- Promoter
- 71.27%
- FII
- 2.60%
- MF
- 13.01%
- Other
- 13.12%
Events
- dividendRs.75.0000 per share(750%)Final Dividend
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- dividendRs.55.0000 per share(550%)Final Dividend (RD dates revised)
- annual General MeetingPOM
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Sanofi Consumer Healthcare India Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals MarketsMojo
Sanofi Consumer Healthcare India Ltd Faces Technical Momentum Shift Amid Sideways Trend MarketsMojo
Sanofi appoints PwC as statutory auditor for five-year term scanx.trade
VIYASH Stock Price and Chart — NSE:VIYASH TradingView
The role of content and consumer education in healthcare marketing Exchange4Media
Mega Dividend Alert! THIS Pharma Stock Is Paying 750% Dividend | How To Get Eligible? Goodreturns
Business information
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- Website
- Not available
- Address
- Not available
- NSE Code
- SANOFICONR
- BSE Code
- 544250
AI analysis
This repository contains no authenticated model-inference API, model version, confidence distribution or forecast timestamp. The Android listing is available; verify report availability, entitlement and pricing inside the app.
Open Google PlayStock FAQ
What is the symbol and ISIN of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has the symbol SANOFICONR and ISIN - INE0UOS01011.
What is the current price of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India is currently trading at INR 4,535.00.
What are the year high and year low of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a year high of INR 5,493.10 and a year low of INR 3,950.50.
What is the market capitalization of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a market capitalization of INR 10,609.81 crore.
What is the P/E ratio of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a P/E ratio of 38.38.
What is the dividend yield of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a dividend yield of 1.64%.
How is the financial performance of Sanofi Consumer Healthcare India based on revenue, net income, and EPS?
Sanofi Consumer Healthcare India has revenue of INR 8,784.00 crore, net income of INR 2,401.00 crore, and EPS of INR 109.80.
What is the book value of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a book value of NA.
What is the debt-to-equity ratio of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a price-to-book ratio of NA and a price-to-sales ratio of 1.21.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.

